Top Medical Searches

Teva’s new asthma inhaler poses first competition for GSK’s Advair

(Reuters) – Teva Pharmaceutical Industries Ltd on Thursday launched an asthma inhaler that will be the first direct competition to GlaxoSmithKline’s best-selling Advair.

 Read more…

Be Sociable, Share!
April 21st, 2017 Posted in Drug
Copyright 2008 © Drugs and Diseases. Developed by Axilosoft
Home | About Us | Privacy Policy | Contact Us